Citation Impact
Citing Papers
Antiseptics and Disinfectants: Activity, Action, and Resistance
1999 Standout
Pseudomonas aeruginosa Biofilms Exposed to Imipenem Exhibit Changes in Global Gene Expression and β-Lactamase and Alginate Production
2004
Characterization of Phenotypic Changes in Pseudomonas putida in Response to Surface-Associated Growth
2001
Alginate Overproduction Affects Pseudomonas aeruginosa Biofilm Structure and Function
2001
Dynamics and Spatial Distribution of β-Lactamase Expression in Pseudomonas aeruginosa Biofilms
2004
Bacterial biofilm shows persistent resistance to liquid wetting and gas penetration
2010
The Pseudomonas aeruginosa accessory genome elements influence virulence towards Caenorhabditis elegans
2019 StandoutNobel
An evaluation of the potential of the multiple antibiotic resistance operon (mar) and the multidrug efflux pump acrAB to moderate resistance towards ciprofloxacin in Escherichia coli biofilms
2000
The clinical impact of bacterial biofilms
2011
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus
2000
Targeting microbial biofilms: current and prospective therapeutic strategies
2017 Standout
Biofilms and antibiotic therapy: Is there a role for combating bacterial resistance by the use of novel drug delivery systems?
2005
Acromegaly
2006 Standout
Understanding biofilm resistance to antibacterial agents
2003 Standout
Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients
2008
Rapid development in vitro and in vivo of resistance to ceftazidime in biofilm‐growing Pseudomonas aeruginosa due to chromosomal β‐lactamase
2000
Surgical Management of GH-Secreting Pituitary Adenomas: An Outcome Study Using Modern Remission Criteria
2001
Biofilm-related infections in ophthalmology
1995
Bacterial competition: surviving and thriving in the microbial jungle
2009 Standout
[25] The MBEC assay system: Multiple equivalent biofilms for antibiotic and biocide susceptibility testing
2001
Insulin-Like Growth Factors I and II. Peptide, Messenger Ribonucleic Acid and Gene Structures, Serum, and Tissue Concentrations*
1989 Standout
Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections
2005 Standout
Changing Epidemiology ofPseudomonas aeruginosa Infection in Danish Cystic Fibrosis Patients (1974-1995)
1999
Sensitivity of biofilms to antimicrobial agents
1993
Visual field defects in 23 acromegalic patients
2013
Relative Increase in IgG Antibodies to Pseudomonas aeruginosa 60-kDa GroEL in Prediabetic Patients with Cystic Fibrosis
2001
In vitro antibacterial properties of magnesium metal against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus☆
2009 StandoutNobel
Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients
2014
Antibiotic resistance of bacteria in biofilms
2001 Standout
Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics
2002
Assessment of Disease Activity in Treated Acromegalic Patients Using a Sensitive GH Assay: Should We Achieve Strict Normal GH Levels for a Biochemical Cure?
2002
Pituitary Irradiation Is Ineffective in Normalizing Plasma Insulin-Like Growth Factor I in Patients with Acromegaly1
1997
Long-Term Evaluation of Postoperative Acromegalic Patients in Remission with Previous and Newly Proposed Criteria
2005
Antibiotic resistance of bacterial biofilms
2010 Standout
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience
2008
Cell-to-Cell Signaling and Pseudomonas aeruginosa Infections
1998
Avidity of anti-P aeruginosa antibodies during chronic infection in patients with cystic fibrosis
1999
Formation and dispersal of bacterial biofilms in vivo and in situ
1993
The Science of Antibiotic Discovery
2020 Standout
Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic
1996
Pseudomonasbiofilm matrix composition and niche biology
2011
Expression of the multiple antibiotic resistance operon (mar) during growth of Escherichia coli as a biofilm
2000
Bacterial biofilms: from the Natural environment to infectious diseases
2004 Standout
Biofilms: an emergent form of bacterial life
2016 Standout
Eradication of biofilm cells of Staphylococcus aureus with tobramycin and cephalexin
1992
Pseudomonas infections in the thermally injured patient
2003
Early intervention and prevention of lung disease in cystic fibrosis: a European consensus
2004
Intravascular-catheter-related infections
1998
Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use
2004
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
A ten year review of Colomycin
2000
Physiological heterogeneity in biofilms
2008 Standout
Acromegaly with Apparently Normal GH Secretion: Implications for Diagnosis and Follow-Up
2002
Factors predicting pituitary adenoma invasiveness in acromegalic patients
1997
and the in vitroand in vivo biofilm mode of growth
2001
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
2020 Standout
Self-Organization, Layered Structure, and Aggregation Enhance Persistence of a Synthetic Biofilm Consortium
2011 StandoutNobel
Piperacillin with and without Tazobactam against Extended-Spectrum Beta-Lactamase-Producing <i>Pseudomonas aeruginosa</i> in a Rat Thigh Abscess Model
2001
Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions
2015 Standout
Reducing implant-related infections: active release strategies
2006 Standout
Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients
2007
In vitro bactericidal activities of beta-lactamases, amikacin, and fluoroquinolones against pseudomonas aeruginosa biofilm in artificial urine
1999
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Treatment of Infections Associated with Surgical Implants
2004 Standout
Nitric Oxide: A Key Mediator of Biofilm Dispersal with Applications in Infectious Diseases
2014
A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance
2003 StandoutNature
Direct Detection of Bacterial Biofilms on the Middle-Ear Mucosa of Children With Chronic Otitis Media
2006 Standout
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria
2017
Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy
1992
Ascertainment and natural history of treated acromegaly in Northern Ireland.
1990
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
2002 Standout
Mucoid conversion of Pseudomonas aeruginos by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung
1999
The role of bacterial biofilms in chronic infections
2013
Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms
2000 StandoutNature
Molecular Mechanisms of β-Lactam Resistance Mediated by AmpC Hyperproduction inPseudomonas aeruginosaClinical Strains
2005
Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)
1993 Standout
Antibiotic Therapy for Chronic Infection of Pseudomonas in the Lung
1993
Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent
2005
A Dose-Response Study of Antibiotic Resistance in Pseudomonas aeruginosa Biofilms
2000
Constitutive High Expression of Chromosomal β-Lactamase in Pseudomonas aeruginosa Caused by a New Insertion Sequence (IS 1669 ) Located in ampD
2002
Preventing Complications of Central Venous Catheterization
2003 Standout
Inorganic polyphosphate is needed for swimming, swarming, and twitching motilities of Pseudomonas aeruginosa
2000 Standout
The physiology and collective recalcitrance of microbial biofilm communities
2002
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Stepwise Upregulation of thePseudomonas aeruginosaChromosomal Cephalosporinase Conferring High-Level β-Lactam Resistance Involves Three AmpD Homologues
2006
AmpC β-Lactamases
2009 Standout
THE ROLE OF ROOT EXUDATES IN RHIZOSPHERE INTERACTIONS WITH PLANTS AND OTHER ORGANISMS
2006 Standout
Bacterial Biofilms: A Common Cause of Persistent Infections
1999 StandoutScience
Statistical Analysis of Pseudomonas aeruginosa Biofilm Development: Impact of Mutations in Genes Involved in Twitching Motility, Cell-to-Cell Signaling, and Stationary-Phase Sigma Factor Expression
2002
Theoretical aspects of antibiotic diffusion into microbial biofilms
1996
Biofilm Susceptibility to Antimicrobials
1997
Benefit of Having MultipleampDGenes for Acquiring β-Lactam Resistance without Losing Fitness and Virulence inPseudomonas aeruginosa
2008
Extended-Spectrum β-Lactamases: a Clinical Update
2005 Standout
Riddle of Biofilm Resistance
2001 Standout
Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance?
2002
The influence of A-band and B-band lipopolysaccharide on the surface characteristics and adhesion of Pseudomonas aeruginosa to surfaces
1996
Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission
2003
Three Decades of β-Lactamase Inhibitors
2010 Standout
Role of Antibiotic Penetration Limitation in Klebsiella pneumoniae Biofilm Resistance to Ampicillin and Ciprofloxacin
2000
Potential of preventing Pseudomonas aeruginosa lung infections in cystic fibrosis patients: Experimental studies in animals
1996
Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
2014 Standout
Wound Healing: A Cellular Perspective
2018 Standout
Bacterial Adhesion: Seen Any Good Biofilms Lately?
2002 Standout
Burn Wound Infections
2006 Standout
Microbial Biofilms: from Ecology to Molecular Genetics
2000 Standout
Prosthetic Joint Infection
2014 Standout
Occurrence of HypermutablePseudomonas aeruginosain Cystic Fibrosis Patients Is Associated with the Oxidative Stress Caused by Chronic Lung Inflammation
2005
Clavulanate Induces Expression of the Pseudomonas aeruginosa AmpC Cephalosporinase at Physiologically Relevant Concentrations and Antagonizes the Antibacterial Activity of Ticarcillin
1999
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
2015
Pseudomonas aeruginosaAmpR Is a Global Transcriptional Factor That Regulates Expression of AmpC and PoxB β-Lactamases, Proteases, Quorum Sensing, and Other Virulence Factors
2005
Biofilms: Microbial Life on Surfaces
2002 Standout
Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms
1994
Chromosomal beta-lactamase is packaged into membrane vesicles and secreted from Pseudomonas aeruginosa
2000
Lung Infections Associated with Cystic Fibrosis
2002 Standout
Transsphenoidal Microsurgery for Growth Hormone-Secreting Pituitary Adenomas: Initial Outcome and Long-Term Results
1998
Garlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections
2005
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
Biofilm Formation as Microbial Development
2000 Standout
Pseudomonas aeruginosa biofilm as a diffusion barrier to piperacillin
1992
Quantification of biofilm structures by the novel computer program comstat
2000 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound
2002
Bioinspired self-repairing slippery surfaces with pressure-stable omniphobicity
2011 StandoutNature
Works of Birgit Giwercman being referenced
[16] Robbins device in biofilm research
1999
Mechanism of Action of Antibiotics in Chronic Pulmonary Pseudomonas Infection
1994
Epidemiology of Pseudomonas aeruginosa in cystic fibrosis and the possible role of contamination by dental equipment
1997
Antibodies against Pseudomonas aeruginosa chromosomal β-lactamase in patients with cystic fibrosis are markers of the development of resistance of P. aeruginosa to β-lactams
1995
INVESTIGATION OF THE CRITERIA FOR ASSESSING THE OUTCOME OF TREATMENT IN ACROMEGALY
1987
Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed β-lactamase producing strains
1990
Polycrylamide gel electrophoresis analysis of lipopolysaccharide fromPseudomonas aeruginosagrowing planktonically and as biofilm
1992
Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.
1994
Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center
1994
Quantitative analysis of the IgG and IgG subclass immune responses to chromosomal Pseudomonas aeruginosa beta-lactamase in serum from patients with cystic fibrosis by western blotting and laser scanning densitometry.
1996
High-level beta-lactamase activity in sputum samples from cystic fibrosis patients during antipseudomonal treatment
1992
[Biofilm, foreign bodies and chronic infections].
1994
Induction of beta-lactamase production in Pseudomonas aeruginosa biofilm
1991